Genomics

Dataset Information

ACSS2 inhibitors act as metabo-immunomodulators in triple negative breast cancer


ABSTRACT: ACSS2 inhibitors act as metabo-immunomodulators in triple negative breast cancer

PROVIDER: PRJNA835329 | ENA |

REPOSITORIES: ENA